Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of cefazolin prophylaxis in TUL surgery
IRCT20160514027893N2Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Oct 2018
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cefazolin in ureterolithiasis, sponsored by North Khorasan University of Medical Sciences. Started Oct 2018; status: completed.
02
Drugs
cefazolin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on IRCT20160514027893N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160514027893N2.